Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -139.74% is in line with its 5-year average of -129.09%, near the high end of its 5-year range (-3916.15%–-22.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.55% below its 12-month average of -133.66%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -139.74%.
RETURN ON INVESTED CAPITAL (ROIC)
-139.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-133.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-138.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-129.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.55%
CURRENT VS 3Y AVG
-1.08%
CURRENT VS 5Y AVG
-8.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-292.02%
vs the sector median at left
RenovoRx, Inc.
Market Cap
$62.62M
Return on Invested Capital (ROIC)
-139.74%
TTM Avg
-133.66%
3Y Avg
-138.24%
5Y Avg
-129.09%
Market Cap
$62.78M
Return on Invested Capital (ROIC)
-6.79%
TTM Avg
-4.87%
3Y Avg
-47.70%
5Y Avg
-62.00%
Market Cap
$63.02M
Return on Invested Capital (ROIC)
-4.72%
TTM Avg
-4.96%
3Y Avg
-2.45%
5Y Avg
-3.32%
Market Cap
$63.78M
Return on Invested Capital (ROIC)
-56.22%
TTM Avg
-67.31%
3Y Avg
-52.91%
5Y Avg
-45.67%
Market Cap
$64.18M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-165.22%
3Y Avg
-160.52%
5Y Avg
-107.11%
Market Cap
$60.42M
Return on Invested Capital (ROIC)
-129.67%
TTM Avg
-97.71%
3Y Avg
-90.63%
5Y Avg
-82.49%
Market Cap
$60.02M
Return on Invested Capital (ROIC)
-1235.48%
TTM Avg
-801.38%
3Y Avg
-433.95%
5Y Avg
-312.84%
Market Cap
$65.85M
Return on Invested Capital (ROIC)
-37.01%
TTM Avg
-30.52%
3Y Avg
-23.08%
5Y Avg
-17.79%
Market Cap
$65.86M
Return on Invested Capital (ROIC)
-83.74%
TTM Avg
-153.15%
3Y Avg
-164.21%
5Y Avg
-165.99%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RenovoRx, Inc. (RNXT) | $62.62M | -139.74% | -133.66% | -138.24% | -129.09% |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | -6.79% | -4.87% | -47.70% | -62.00% |
| InterCure Ltd. (INCR)vs › | $63.02M | -4.72% | -4.96% | -2.45% | -3.32% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | -56.22% | -67.31% | -52.91% | -45.67% |
| Alps Group Inc (ALPS)vs › | $64.18M | N/A | -165.22% | -160.52% | -107.11% |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | -129.67% | -97.71% | -90.63% | -82.49% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | -1235.48% | -801.38% | -433.95% | -312.84% |
| XBiotech Inc. (XBIT)vs › | $65.85M | -37.01% | -30.52% | -23.08% | -17.79% |
| Cingulate Inc. (CING)vs › | $65.86M | -83.74% | -153.15% | -164.21% | -165.99% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | N/A | -86.10% | -83.22% | -74.34% |
ROIC
-139.7%
ROE
-136.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -139.74% |
| 2026-03-31 | -106.86% |
| 2025-12-31 | -203.99% |
| 2025-09-30 | -124.65% |
| 2025-06-30 | -93.06% |
| 2025-03-31 | -81.27% |
| 2024-12-31 | -176.68% |
| 2024-09-30 | -122.47% |
| 2024-06-30 | -96.04% |
| 2024-03-31 | -600.51% |
| 2023-12-31 | -3916.15% |
| 2023-09-30 | -615.94% |
| 2023-06-30 | -237.64% |
| 2023-03-31 | -313.45% |
| 2022-12-31 | -161.45% |
| 2022-09-30 | -124.40% |
| 2022-06-30 | -92.59% |
| 2022-03-31 | -60.78% |
| 2021-12-31 | -36.94% |
| 2021-09-30 | -22.52% |
| 2021-06-30 | -1806.25% |
| 2020-12-31 | -547.69% |
